99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY
99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY99%+ VERIFIED PURITYTHIRD-PARTY TESTED LOTSFREE SHIPPING ON ORDERS $250+FREE EXPRESS SHIPPING ON ORDERS $500+FAST ORDER FULFILLMENTFOR RESEARCH USE ONLY
Research Verification
RVA Peptides supplies research compounds exclusively to qualified researchers and laboratories for in-vitro research use. Please confirm the statements below before continuing.
Select the category that best describes your research role.
✓ Third-party tested◉ ≥99% purity▣ Documented COA○ Research use only
$68.50–$115.00Price range: $68.50 through $115.00
GLP-3 RT is a 39-amino acid research peptide associated with GIP, GLP-1, and glucagon receptor pathways. Supplied as a lyophilized material for controlled in-vitro laboratory research only.
This peptide is intended for laboratory research purposes only and must be handled by trained professionals in controlled research environments.
DISCLAIMER
Not for human consumption or medical use. This product is not intended to diagnose, treat, cure, or prevent any disease. Use only in accordance with applicable research standards and regulations.
TERMS OF SALE
By purchasing from RVA Peptides, the buyer acknowledges they are qualified to handle research compounds and assumes full responsibility for proper use, handling, and storage.
Reviews
There are no reviews yet.